MIRA Pharmaceuticals, Inc.
MIRA
$0.9389
-$0.1311-12.25%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.83M | 4.14M | 2.82M | 3.53M | 4.60M |
| Total Receivables | -- | -- | -- | -- | 11.90K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 54.70K | 86.60K | 108.60K | 185.30K | 243.80K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 2.89M | 4.23M | 2.93M | 3.71M | 4.86M |
|
|
|||||
| Total Current Assets | 2.89M | 4.23M | 2.93M | 3.71M | 4.86M |
| Net Property, Plant & Equipment | -- | -- | -- | 1.30K | 5.10K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 35.40K | 35.40K | 83.20K | 93.50K | 69.20K |
| Total Assets | 2.92M | 4.27M | 3.02M | 3.81M | 4.93M |
|
|
|||||
| Total Accounts Payable | 723.30K | 692.80K | 782.10K | 636.30K | 538.60K |
| Total Accrued Expenses | -- | -- | 14.50K | 14.50K | 14.50K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | 1.30K | 5.10K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 723.30K | 692.80K | 796.60K | 652.00K | 558.10K |
|
|
|||||
| Total Current Liabilities | 723.30K | 692.80K | 796.60K | 652.00K | 558.10K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 723.30K | 692.80K | 796.60K | 652.00K | 558.10K |
|
|
|||||
| Common Stock & APIC | 31.34M | 30.31M | 26.91M | 26.16M | 25.66M |
| Retained Earnings | -29.14M | -26.74M | -24.69M | -23.00M | -21.29M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 2.20M | 3.57M | 2.22M | 3.16M | 4.37M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.20M | 3.57M | 2.22M | 3.16M | 4.37M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.20M | 3.57M | 2.22M | 3.16M | 4.37M |
|
|
|||||